Ukraine HIV Therapeutics Market Analysis

Ukraine HIV Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the Ukraine HIV therapeutics market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Lekhim, Darnitsa, and Farmak. The market is driven by government policies and initiatives for the management of HIV infections in the country amidst the war situation. The HIV therapeutics market in Ukraine is segmented by type, product, and geography, end user, and distribution channel.

ID: IN10UAPH037 CATEGORY: Pharmaceuticals GEOGRAPHY: Ukraine AUTHOR: Dr. Vishwa Modhia

Buy Now

Ukraine HIV Therapeutics Market Analysis Summary

By 2030, it is anticipated that the Ukraine HIV therapeutics market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-2030.

Ukraine is an Eastern European country bordered by the Black Sea and the Sea of Azov. According to the most recent WHO data, HIV/AIDS-related deaths in Ukraine reached 3100 in 2020. With an age-adjusted death rate of 11.51 per 100,000 people, Ukraine ranks 55th in the world. In 2020, the adult prevalence of HIV/AIDS in Ukraine was 1%, ranking 44th globally with 2,60,000 HIV cases.

According to Ministry of Health data, the Dnipropetrovsk region ranks first in Ukraine in terms of AIDS mortality and is one of the top three regions with the highest prevalence of HIV infections. Before the war, Ukraine was making good progress in its National AIDS response. The number of people living with HIV and receiving antiretroviral (ARV) treatment grew steadily, reaching 132,239 by the beginning of 2022. Ukraine spent 7.6% of its GDP on healthcare in 2019.

Market Dynamics

Market Growth Drivers

Ukraine was the only EECA country (Eastern European and Central Asian countries) where the government funded a basic package of HIV prevention services in key populations from the state budget. Ukraine has shown remarkable resilience in its HIV response. Today, thanks to partners such as the Global Fund and the United States President's Emergency Plan for AIDS Relief (PEPFAR), Ukraine has received enough ARV medicines to ensure that no one with HIV/AIDS is left behind. Due to these factors, once the situation improves, there are chances of growth of Ukraine HIV therapeutics market.

Market Restraints

More than 7.9 Mn Ukrainians have fled to other countries as a result of the war, while another 6.5 Mn are internally displaced within the country. Because of destruction or occupation, more than 30 medical institutions providing HIV services have ceased operations. Logistical chains were also broken. Due to the war crisis, many players will not enter the HIV therapeutics market in Ukraine.

Competitive Landscape

Key Players

  • Farmak (UKR)
  • Darnitsa (UKR)
  • Lekhim (UKR)
  • Arterium (UKR)
  • Gilead Sciences
  • AbbVie
  • Roche

Recent Notable Update

April 2022: President's Emergency Plan for AIDS Relief (PEPFAR) donated HIV medications such as ART are being distributed to Ukrainian refugees in Poland, the Czech Republic, and other European Union countries with the assistance of drugmaker ViiV Healthcare. PEPFAR has invested a total of $13 Mn in emergency funding over the last two months to procure 51 Mn doses of antiretroviral medications (ARVs), enough to meet the urgent treatment needs of Ukrainians living with HIV for up to a year. PEPFAR initially provided 18 Mn doses of the ARVs tenofovir, lamivudine, and dolutegravir (TLD). These medications are already being rapidly distributed to HIV-positive people across Ukraine.

Healthcare Regulations and Reimbursement Policies

In Ukraine, HIV therapeutics are regulated by the Ministry of Health's State Expert Center (SEC). The SEC is in charge of evaluating and approving new HIV drugs on the basis of quality, safety, and efficacy. HIV medications are considered prescription-only medications and must be administered by licensed pharmacies or healthcare facilities. The Ukrainian government provides free antiretroviral therapy to HIV patients and collaborates with international organizations to increase the availability and affordability of HIV treatments in the country.

HIV therapeutics are reimbursed through Ukraine's national health insurance system. Through the National AIDS and STI Control Program, the government provides free antiretroviral therapy to all people living with HIV, regardless of their legal or social status. The program covers the cost of HIV medications as well as laboratory tests, medical consultations, and other HIV-related services. Furthermore, international organizations such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria provide financial support to Ukraine's HIV response, which helps to ensure the country's HIV treatment availability and affordability.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

HIV Therapeutics Segmentation

By Types (Revenue, USD Billion):

  • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • Coreceptor Antagonists
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
  • Protease Inhibitors (PIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 19 February 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up